Millennium Management’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
Other funds holding AMRX
TGA
VPM
RCMNY
VCM
Millennium Management's AMRX Position: Q1 2026 in Review
Millennium Management reduced its Amneal Pharmaceuticals (AMRX) stake by 89% in Q1 2026, selling an estimated $40.2M and leaving 369,733 shares worth $4.6M. The position accounts for ﹤0.01% of the portfolio, ranked #3043.
Millennium Management first reported a position in AMRX in Q2 2018 and has held it in 28 quarters since. The position peaked at $42.3M in Q4 2025. 315 funds tracked by Wall St. Rank hold AMRX as of Q1 2026.
- Millennium Management held 369,733 shares of Amneal Pharmaceuticals worth $4.6M as of Q1 2026.
- Millennium Management sold 2,990,465 Amneal Pharmaceuticals shares in Q1 2026, an estimated $40.2M.
- Amneal Pharmaceuticals made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3043 holding.
- Millennium Management first reported a position in Amneal Pharmaceuticals in Q2 2018 and has held it in 28 quarters since.
- Millennium Management's Amneal Pharmaceuticals position peaked at $42.3M in Q4 2025.
- 315 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.